Cargando…

Cervicovaginal Complement Activation and Microbiota During Pregnancy and in Parturition

BACKGROUND: Vaginal microbiome and the local innate immune defense, including the complement system, contribute to anti- and proinflammatory homeostasis during pregnancy and parturition. The relationship between commensal vaginal bacteria and complement activation during pregnancy and delivery is no...

Descripción completa

Detalles Bibliográficos
Autores principales: Livson, Sivan, Virtanen, Seppo, Lokki, A. Inkeri, Holster, Tiina, Rahkonen, Leena, Kalliala, Ilkka, Nieminen, Pekka, Salonen, Anne, Meri, Seppo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358961/
https://www.ncbi.nlm.nih.gov/pubmed/35958597
http://dx.doi.org/10.3389/fimmu.2022.925630
_version_ 1784764039737376768
author Livson, Sivan
Virtanen, Seppo
Lokki, A. Inkeri
Holster, Tiina
Rahkonen, Leena
Kalliala, Ilkka
Nieminen, Pekka
Salonen, Anne
Meri, Seppo
author_facet Livson, Sivan
Virtanen, Seppo
Lokki, A. Inkeri
Holster, Tiina
Rahkonen, Leena
Kalliala, Ilkka
Nieminen, Pekka
Salonen, Anne
Meri, Seppo
author_sort Livson, Sivan
collection PubMed
description BACKGROUND: Vaginal microbiome and the local innate immune defense, including the complement system, contribute to anti- and proinflammatory homeostasis during pregnancy and parturition. The relationship between commensal vaginal bacteria and complement activation during pregnancy and delivery is not known. OBJECTIVE: To study the association of the cervicovaginal microbiota composition to activation and regulation of the complement system during pregnancy and labor. STUDY DESIGN: We recruited women during late pregnancy (weeks 41 + 5 to 42 + 0, n=48) and women in active labor (weeks 38 + 4 to 42 + 2, n=25). Mucosal swabs were taken from the external cervix and lateral fornix of the vagina. From the same sampling site, microbiota was analyzed with 16S RNA gene amplicon sequencing. A Western blot technique was used to detect complement C3, C4 and factor B activation and presence of complement inhibitors. For semiquantitative analysis, the bands of the electrophoresed proteins in gels were digitized on a flatbed photo scanner and staining intensities were analyzed using ImageJ/Fiji win-64 software. Patient data was collected from medical records and questionnaires. RESULTS: The vaginal microbiota was Lactobacillus-dominant in most of the samples (n=60), L. iners and L. crispatus being the dominant species. L. gasseri and L. jensenii were found to be more abundant during pregnancy than active labor. L. jensenii abundance correlated with C4 activation during pregnancy but not in labor. Gardnerella vaginalis was associated with C4 activation both during pregnancy and labor. The amount of L. gasseri correlated with factor B activation during pregnancy but not during labor. Atopobium vaginae was more abundant during pregnancy than labor and correlated with C4 activation during labor and with factor B activation during pregnancy. Activation of the alternative pathway factor B was significantly stronger during pregnancy compared to labor. During labor complement activation may be inhibited by the abundant presence of factor H and FHL1. CONCLUSIONS: These results indicate that bacterial composition of the vaginal microbiota could have a role in the local activation and regulation of complement-mediated inflammation during pregnancy. At the time of parturition complement activation appears to be more strictly regulated than during pregnancy.
format Online
Article
Text
id pubmed-9358961
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93589612022-08-10 Cervicovaginal Complement Activation and Microbiota During Pregnancy and in Parturition Livson, Sivan Virtanen, Seppo Lokki, A. Inkeri Holster, Tiina Rahkonen, Leena Kalliala, Ilkka Nieminen, Pekka Salonen, Anne Meri, Seppo Front Immunol Immunology BACKGROUND: Vaginal microbiome and the local innate immune defense, including the complement system, contribute to anti- and proinflammatory homeostasis during pregnancy and parturition. The relationship between commensal vaginal bacteria and complement activation during pregnancy and delivery is not known. OBJECTIVE: To study the association of the cervicovaginal microbiota composition to activation and regulation of the complement system during pregnancy and labor. STUDY DESIGN: We recruited women during late pregnancy (weeks 41 + 5 to 42 + 0, n=48) and women in active labor (weeks 38 + 4 to 42 + 2, n=25). Mucosal swabs were taken from the external cervix and lateral fornix of the vagina. From the same sampling site, microbiota was analyzed with 16S RNA gene amplicon sequencing. A Western blot technique was used to detect complement C3, C4 and factor B activation and presence of complement inhibitors. For semiquantitative analysis, the bands of the electrophoresed proteins in gels were digitized on a flatbed photo scanner and staining intensities were analyzed using ImageJ/Fiji win-64 software. Patient data was collected from medical records and questionnaires. RESULTS: The vaginal microbiota was Lactobacillus-dominant in most of the samples (n=60), L. iners and L. crispatus being the dominant species. L. gasseri and L. jensenii were found to be more abundant during pregnancy than active labor. L. jensenii abundance correlated with C4 activation during pregnancy but not in labor. Gardnerella vaginalis was associated with C4 activation both during pregnancy and labor. The amount of L. gasseri correlated with factor B activation during pregnancy but not during labor. Atopobium vaginae was more abundant during pregnancy than labor and correlated with C4 activation during labor and with factor B activation during pregnancy. Activation of the alternative pathway factor B was significantly stronger during pregnancy compared to labor. During labor complement activation may be inhibited by the abundant presence of factor H and FHL1. CONCLUSIONS: These results indicate that bacterial composition of the vaginal microbiota could have a role in the local activation and regulation of complement-mediated inflammation during pregnancy. At the time of parturition complement activation appears to be more strictly regulated than during pregnancy. Frontiers Media S.A. 2022-07-25 /pmc/articles/PMC9358961/ /pubmed/35958597 http://dx.doi.org/10.3389/fimmu.2022.925630 Text en Copyright © 2022 Livson, Virtanen, Lokki, Holster, Rahkonen, Kalliala, Nieminen, Salonen and Meri https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Livson, Sivan
Virtanen, Seppo
Lokki, A. Inkeri
Holster, Tiina
Rahkonen, Leena
Kalliala, Ilkka
Nieminen, Pekka
Salonen, Anne
Meri, Seppo
Cervicovaginal Complement Activation and Microbiota During Pregnancy and in Parturition
title Cervicovaginal Complement Activation and Microbiota During Pregnancy and in Parturition
title_full Cervicovaginal Complement Activation and Microbiota During Pregnancy and in Parturition
title_fullStr Cervicovaginal Complement Activation and Microbiota During Pregnancy and in Parturition
title_full_unstemmed Cervicovaginal Complement Activation and Microbiota During Pregnancy and in Parturition
title_short Cervicovaginal Complement Activation and Microbiota During Pregnancy and in Parturition
title_sort cervicovaginal complement activation and microbiota during pregnancy and in parturition
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358961/
https://www.ncbi.nlm.nih.gov/pubmed/35958597
http://dx.doi.org/10.3389/fimmu.2022.925630
work_keys_str_mv AT livsonsivan cervicovaginalcomplementactivationandmicrobiotaduringpregnancyandinparturition
AT virtanenseppo cervicovaginalcomplementactivationandmicrobiotaduringpregnancyandinparturition
AT lokkiainkeri cervicovaginalcomplementactivationandmicrobiotaduringpregnancyandinparturition
AT holstertiina cervicovaginalcomplementactivationandmicrobiotaduringpregnancyandinparturition
AT rahkonenleena cervicovaginalcomplementactivationandmicrobiotaduringpregnancyandinparturition
AT kallialailkka cervicovaginalcomplementactivationandmicrobiotaduringpregnancyandinparturition
AT nieminenpekka cervicovaginalcomplementactivationandmicrobiotaduringpregnancyandinparturition
AT salonenanne cervicovaginalcomplementactivationandmicrobiotaduringpregnancyandinparturition
AT meriseppo cervicovaginalcomplementactivationandmicrobiotaduringpregnancyandinparturition